Phio Pharmaceuticals Corp. (PHIO:NASDAQ) closed at $0.771 on November 13, 2026, down 5.03% on the day. The stock trades 59.0% below its 52-week high of $1.88 and 2.8% above its 52-week low of $0.750. Over the past year, it lost 40.7%. Phio Pharmaceuticals Corp. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 13, 2025, PHIO closed higher on 110 days (44%). Its best day was February 13, 2026 (+35.25%) and its worst was February 18, 2026 (-21.09%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.
RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
Find more stocks like PHIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.